OmniAb Statistics
NASDAQ: OABIHealthcareBiotechnologyUSD
4.66+0.10 (+2.19%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
OmniAb by the numbers
OmniAb has a market capitalization of $677.5 million based on 145.39M shares outstanding. With trailing EPS of $-0.36, OmniAb is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 14.3% above its 50-day average and 88.8% above its 200-day average.
Average daily trading volume is 1.47M shares, or about $6.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
OABI valuation vs. peer median
| Metric | OABI | Peer median | Difference |
|---|---|---|---|
| Market cap | $677.52M | $736.82M | -8% |
| Avg. volume | 1.47M | 1.30M | +13% |
Peer median across 8 companies: NVCT, VSTM, CADL, ATTO, ANNX, SLN, DNA, PHAT.
Valuation
- Market cap
- $677.52M
- EPS (TTM)
- $-0.36
- Shares outstanding
- 145.39M
Price and trading
- Previous close
- 4.56
- Open
- 4.49
- Day range
- 4.22 – 4.66
- 52-week range
- 1.30 – 5.43
- 52-week change
- +166.29%
- Beta
- —
- Volume
- 1.53M
- Average volume
- 1.47M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 3, 2026
Additional statistics
- Market Cap
- 677.52M
- Forward Pe
- -15.93
- Eps
- -0.36
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 5.43
- Week52 Low
- 1.30
- Avg Volume
- 1.47M
- Shares Outstanding
- 145.39M
- Ma50
- 4.08
- Ma200
- 2.47
- Earnings Date
- Nov 3, 2026
- Pct From52w High
- -14.18%
- Pct From52w Low
- 258.46%